Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Birch pollen allergen extract is a standardized biologic preparation derived from the pollens of the birch tree (Betula species), primarily used for allergy immunotherapy in individuals with moderate to severe allergic rhinitis or rhinoconjunctivitis caused by exposure to birch and related tree pollens (alder, hazel, oak). The mechanism of action involves gradual desensitization of the immune system through controlled exposure to small amounts of the relevant allergens. This can be administered as sublingual tablets (SLIT) or via injection as part of immunotherapy regimens. Over time, this leads to reduced sensitivity and symptoms upon natural exposure. Birch pollen extracts are also used in allergy testing (skin prick tests). Clinical trials have demonstrated efficacy in reducing both symptoms and medication use during tree-pollen seasons[3][4][6][8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on birch pollen allergen extract.